Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

WeightWatchers is shaking up its leadership. WW International announced Friday that CEO Sima Sistani would leave her role ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...

The safety of a calorie deficit for weight loss depends on things like your starting weight, overall health and unique ...

Food, exercise, sleep, hydration. So much goes into weight loss. But how does weight loss work, exactly? In the simplest ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...